EP Patent

EP4538259A1 — Processes for the preparation of deucravacitinib

Assigned to Farmhispania Group SL · Expires 2025-04-16 · 1y expired

What this patent protects

The invention relates to processes for the preparation of deucravacitinib of formula (XI), or a pharmaceutically acceptable salt thereof. It also relates to intermediates of formula (V') and (V") as defined herein useful in the synthesis of this molecule.

USPTO Abstract

The invention relates to processes for the preparation of deucravacitinib of formula (XI), or a pharmaceutically acceptable salt thereof. It also relates to intermediates of formula (V') and (V") as defined herein useful in the synthesis of this molecule.

Drugs covered by this patent

Patent Metadata

Patent number
EP4538259A1
Jurisdiction
EP
Classification
—
Expires
2025-04-16
Drug substance claim
No
Drug product claim
No
Assignee
Farmhispania Group SL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.